COMPLEX APPROACH TO BORDER NEURO - PSYCHIC DISORDERS TREATMENT
This study inscribes the effectiveness of an integrated approach to the treatment of borderline neuro-psychiatric disorders. 50 patients had examined, in which women - 39 (78%), men- 11 persons (22%) were observed in dynamic of treatment. We applied the principle of differential, incremental, integrated approach to the treatment of patients with neuroses. Designed program of a comprehensive approach to treatment of patients with borderline neuro-psychiatric disorders consisted of five phases: diagnostic, activating, reconstructive, train and maintain. The complex treatment focused on the study and recon-struction of the patient's personality, his system of values, the relationship with the outside world, restoring full of his social functioning.
A.A. Almagambetova
OSCC "Mental health centers" of Semey city
1. Абабков В.А. Неврозы / В.А. Абабков. - СПб. - 2002. - 160 с.
2. Карвасарский Б.Д. Неврозы. Руководство для врачей. – М.: Медицина, 1990. - 573 с.
3. Пезешкиан Н. Основы позитивной психотерапии. – Архангельск: Издательство Архангельского медицинского института, 1993- 116 c.
4. Носсрат Пезешкиан. Психосоматика и позитивная психотерапия. Москва «Медицина» - 1996. - 463 с.
5. Сгибов В.Н. Комплексная терапия невротических расстройств в негосударственном учреждении здраво-охранения «Научно-практический центр «Психотерапия» // Неврозы в современном мире. Новые концепции и подходы к терапии: сборник тезисов научно-практической конференции с международным участием, 3-4 февраля 2011 г. – СПб. 2011. – С. 193-194.
6. Карвасарский Б.Д. Психотерапия. – Москва «Ме-дицина» - 1985. - 304 с.
7. Лоуэн А. Радость. (Перевод с анг. Е.Г. Гендель). Минск О.О.О. «Попурри» - 1999. - 464 с.
Number of Views: 126
Related publications:
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY